Transdermal nicotine appears to be superior to placebo for the induction of remission in patient's with ulcerative colitis but there is no evidence of any significant advantage compared to standard medical therapy Transdermal Nicotine for Induction of Remission in Ulcerative Colitis.
Tacrolimus may be effective for short-term improvement in symptoms in patients with treatment resistant ulcerative colitis at the cost of potential serious side effects. Insufficient treatment and follow-up intervals prevent any conclusions with regard to long-term safety and efficacy Tacrolimus (Fk506) for Induction of Remission in Refractory Ulcerative Colitis.